Endocrine effects of erythropoietin in cancer patients

Hematology

Volumn 9, Issue 5-6, 2004, Pages 363-367

  Lissoni, Paolo ^a   Perego, Maristella ^a   Veronese, Elisabetta ^a   Fumagalli, Gabriele ^a   Brivio, Fernando ^a   Colciago, Massimo ^b   Messina, Giusy ^a   Rovelli, Franco ^a   Brivio, Rinaldo ^a   Gardani, Gianstefano ^a  

^a SAN GERARDO HOSPITAL   (Italy)

^b GENERAL HOSPITAL   (Italy)

Author keywords

Erythropoietin; Growth hormone; Insulin like growth factor 1; Tumor growth factors

Indexed keywords

ERYTHROPOIETIN; FOLLITROPIN; GROWTH HORMONE; HYDROCORTISONE; LUTEINIZING HORMONE; PRASTERONE SULFATE; PROLACTIN; SOMATOMEDIN C; THYROTROPIN;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; CANCER INHIBITION; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; ENDOCRINE FUNCTION; FOLLITROPIN BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HORMONAL REGULATION; HORMONE INHIBITION; HORMONE RELEASE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOPHYSIS; LUTEINIZING HORMONE BLOOD LEVEL; MALE; PRIORITY JOURNAL; SOLID TUMOR; STATISTICAL SIGNIFICANCE; THYROTROPIN BLOOD LEVEL;

AGED; ANEMIA; ERYTHROPOIETIN; FEMALE; HORMONES; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; NEOPLASMS; RECOMBINANT PROTEINS;

EID: 19944427351     PISSN: 10245332     EISSN: None     Source Type: Journal    
DOI: 10.1080/10245330400001876     Document Type: Article

References (17)

1. Lissoni, P., Fumagalli, E., Malugani, F., Ardizzoia, A., Bucocev, R., Tancini, G. and Gardani, G.S. (2001) "Stimulation of IL-2 secretion by GM-CSF in advanced cancer patients", J. Biol. Regul. Homeost. Agents 15, 163-165.
2. Crispino, S., Lissoni, P., Ardizzoia, A., Barni, S., Rovelli, F. and Tancini, G. (1992) "Effects of granulocyte-macrophage colony-stimulating factor on cortisol, growth hormone, prolactin and melatonin in cancer patients", J. Biol. Regul. Homeost. Agents 6, 142-144.
3. Rovelli, F., Barni, S., Tancini, G., Ardizzoia, A. and Lissoni, P. (1995) "Endocrine effects of granulocyte colony-stimulating factor in cancer patients", Tumori 81, 438-439.
4. Myslowska, J., Bryl, B. and Szolkiewicz, M. (1996) "Low doses of recombinant human erythropoietin raise serum interleukin-2 levels in hemodialysis patients", J. Nephrol. 9, 30-34.
5. Lissoni, P., Rovelli, F., Baiocco, N., Tancini, G. and Fumagalli, L. (2001) "A phase H study of subcutaneous low-dose interleukin-2 plus erythropoietin in metastatic renal cell carcinoma progressing on interleukin-2 alone", Anticancer Res. 21, 777-780.
6. Ferrara, N., Houck, K.A., Jakeman, L.B. and Leung, D.W. (1992) "Molecular and biological properties of the vascular endothelial growth factor family of proteins", Endocrine Rev. 13, 18-32.
7. Tung-Ping Pong, R., Fan, S.T. and Wong, J. (2001) "Clinical implications of circulating angiogenic factors in cancer patients", J. Clin. Oncol. 19, 1207-1225.
8. Blay, J.Y., Pallardy, M., Ravaud, A., Caux, C., Negrier, S., Douillard, J.Y., Chevreau, C., Fleury, J., Ray, I., Escudier, R. and Lasset, C. (1999) "Serum VEGF is an indipendent prognostic factor in patients with metastatic renal carcinoma treated with IL-2 and/or IFN: analysis of the CRECY trial", Proc. Am. Soc. Clin. Oncol. 18 1669, (abstr.).
9. Pedram, A., Razandi, M., Hy, R.M. and Levin, E.R. (1997) "Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion", J. Biol. Chem. 272, 17097-17103.
10. Bagnato, A. and Catt, K.C. (1998) "Endothelins as autocrine regulators of tumor cell growth", Trends Endocrinol. Metab. 9 378-383.
11. Shwiki, D., Itin, A., Soffer, D. and Keshet, E. (1992) "Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis", Nature 359, 843-845.
12. Alvarez Arroyo, M.V., Castilla, M.A., Gonzales Pacheco, F.R., Tan, D., Riesco, A., Casado, S. and Carmelo, C. (1998) "Role of vascular endothelial growth factor on erythropoietin-related on endothelial cell proliferation", J. Am. Soc. Nephrol. 9, 1998-2004.
13. Rizzo, J.D., Lichtin, A.E., Woolf, S.H., Seidenfeld, J., Bennet, C.L., Cella, D., Djulbegovic, B., Goode, M.J., Jakubowski, A.A., Lee, S.J., Miller, C.B., Rarik, M.U., Regan, D.H., Browman, G.P. and Gordon, M.S. (2002) "Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of of hematology", J. Clin. Oncol. 20, 4083-4107.
14. Roberts, A.B. and Sporn, A.B. (1986) "Growth factors and transformation", Cancer Surv. 5, 405-411.
15. Grellier, P., Chanson, P., Casadevall, N., Abboud, S. and Schaison, G. (1996) "Remission of polycythemia vera after surgical care of acromegaly", Ann. Intern. Med. 124, 495-496.
16. Frank, S.J. (2002) "GRH-somatostatin-GH", Endocrinology 143, 2-10.
17. Tancini, G., Lissoni, P., Brivio, F., Rovelli, F., Fumagalli, G., Pescia, S., Vegetti, G., Rivolta, A. and Barni, S. (1994) Abnormally high serum levels of somatomedin-C in patients with operable breast carcinoma", J. Endocrinol. Invest. 17(Suppl. 1), 83, (abstr.).